A developmental hypothesis to explain the multicentricity of breast cancer

CMAJ. Canadian Medical Association Journal

Volumn 159, Issue 1, 1998, Pages 55-59

  Sharpe, Colin R ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; DISEASE PREDISPOSITION; EPITHELIUM CELL; FEMALE; GENE MUTATION; GROWTH; HUMAN; HYPOTHESIS; MALIGNANT TRANSFORMATION; STEM CELL;

EID: 0032516514     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Fisher ER, Gregorio R, Redmond C, Vellios F, Sommers SC, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Proiect (protocol no. 4). 1. Observations concerning the multicentricity of mammary cancer. Cancer 1975;35:247-54.
2. Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. Pathol Annu 1981;16(pt 2):83-102.
3. Anastassiades O, Iakovou E, Stavridou N, Gogas J, Karameris A. Multicentricity in breast cancer. A study of 366 cases. Am J Clin Pathol 1993;99:238-43.
4. Sacchini V. Multicentricity and recurrence of breast cancer. Lancet 1996;348:1256-7.
5. Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, Imaoka S. Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis. Cancer 1994;74:872-7.
6. Love SM, Barsky SH. Breast-duct endoscopy to study stages of cancerous breast disease. Lancet 1996;348:997-9.
7. Schnitt SJ, Silen W, Sadowsky NL, Connolly JL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988;318: 898-903.
8. Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Stekhoven JHS. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
9. Lagios MD, Westdahl PR, Margolin FR, Rose ME. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-14.
10. Alpers CE, Wellings SR. The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 1985;16:796-807.
11. Foote FW, Stewart FW. Lobular carcinoma in situ. A rare form of mammary cancer. Am J Pathol 1941;17:491-6.
12. Lambird PA, Shelly WM. The spatial distribution of lobular in situ mammary carcinoma. JAMA 1969;210:689-93.
13. Ruddon RW. Molecular and genetic events in neoplastic transformation. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press; 1996. p. 80-100.
14. Heim S, Mitelman F. Tumors of the breast. In: Cancer cytogenetics. 2nd ed. New York: Wiley-Liss; 1995. p. 369-88.
15. Greene MH. Genetics of breast cancer. Mayo Clin Proc 1997;72:54-65.
16. Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 1995;4:567-71.
17. Merzenich H, Boeing H, Wahrendorf J. Dietary fat and sports activity as determinants for age at menarche. Am J Epidemiol 1993;138:217-24.
18. Tulinius H, Day NE, Johannesson G, Bjarnason O, Gonzales M. Reproductive factors and risk of breast cancer in Iceland. Int J Cancer 1978;21:724-30.
19. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, et al. Age at first birth and breast cancer risk. Bull World Health Organ 1970;43:209-21.
20. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997;278:1407-11.
21. Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997;336:1269-75.
22. Smith-Warner SA, Spiegelman D, Yaun S, van den Brandt PA, Folsom AR, Goldhohm RA, et al. Alcohol and breast cancer in women. A pooled analysis of cohort studies. JAMA 1998;279:535-40.
23. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
24. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
25. Ambrosone CB, Freudenhaim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 1996;276:1494-501.
26. Hunter DJ, Hankinson SE, Hough H, Gertig DM, Garcia-Closas M, Spiegelman D, et al. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis 1997;18:2127-32.
27. Sharkey FE, Allred DC, Valente PT: Breast. In: Danjanov I, Linder J, editors. Anderson's pathology. 10th ed. St. Louis: Mosby; 1996. p. 2354-88.
28. Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hoshi K, et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 1995;76:32-45.
29. Suzuki DT, Griffiths AJF, Miller JH, Lewontin RC. An introduction to genetic analysis. 4th ed. New York: WH Freeman; 1989. p. 379-82.
30. Teixeira MR, Pandis N, Bardi G, Andersen JA, Mandahl N, Mitelman F, et al. Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br J Cancer 1994;70:922-7.
31. Connolly JL, Harris JR, Schnitt SJ. Understanding the distribution of cancer within the breast is important for optimizing breast-conserving treatment. Cancer 1995;76:1-3.
32. Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994;74:1746-51.
33. Johnson JE, Page DL, Winfield AC, Reynolds VH, Sawyers JL. Recurrent mammary carcinoma after local excision. A segmental problem. Cancer 1995;75:1612-8.
34. Russo J, Russo IH. Development of the human mammary gland. In: Neville MC, Daniel CW, editors. The mammary gland. Development, regulation, and function. New York: Plenum Press; 1987. p. 67-93.
35. Tsai YC, Lu Y, Nichols PW, Zlotnikov G, Jones PA, Smith HS. Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res 1996;56:402-4.
36. Moolgavkar SH, Knudson AG. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst 1981;66:1037-52.
37. Moolgavkar SH, Day NE, Stevens RG. Two-stage model for carcinogenesis: epidemiology of breast cancer in females. J Natl Cancer Inst 1980;65:559-69.
38. Moolgavkar SH. A two-stage carcinogenesis model for risk assessment. Cell Biol Toxicol 1989;5:445-60.
39. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990;249:1007-11.
40. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415-21.
41. Thilly WG. Looking ahead: algebraic thinking about genetics, cell kinetics and cancer. IARC Sci Publ 1988;89:486-92.
42. Mohrenweiser H, Zingg B. Mosaicism: the embryo as a target for induction of mutations leading to cancer and generic disease [review]. Environ Mol Mutagen 1995;25(Suppl 26):21-9.
43. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982;2:5-73.
44. John KM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev 1993;15:157-62.
45. O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 1994;32:5-12.
46. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-9.
47. Cha RS, Thilly WG, Zarbl H. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations. Proc Natl Acad Sci U S A 1994;91:3749-53.
48. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A 1994;91:9871-5.
49. Rosenberg CL, de las Morenas A, Huang K, Cupples LA, Falter DV, Larson PS. Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. J Clin Invest 1996;98:1095-100.
50. Heim S, Mitelman F. Cytogenetic methods and terminology. In: Cancer cytogenetics. 2nd ed. New York: Wiley-Liss; 1995. p. 8-9.
51. Nuovo GJ. PCR in situ hybridization. Protocols and applications. 2nd ed. New York: Raven Press; 1994.